U.S. market Closed. Opens in 1 day 8 hours 51 minutes

ALZN | Alzamend Neuro, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue50.74K23.07KN/AN/AN/AN/AN/AN/AN/A
Gross Profit-50.74K-23.07KN/AN/AN/AN/AN/AN/AN/A
Operating Expenses9.94M14.87M12.32M4.95M4.42M5.01M898.43K1.55M69.46K
Selling, General & Admin3.48M7.42M7.12M3.64M3.35M1.31M575.03K1.27M69.46K
Research & Development6.46M7.45M5.20M1.31M1.07M3.70M323.40K275.05KN/A
Other Operating Expenses0N/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-9.94M-14.87M-12.32M-4.95M-4.42M-5.01M-898.43K-1.55M-69.46K
Other Expenses / Income-10.10K-7.70K-42.52K-94.68K13.93K146.39K-33.23K-21.50KN/A
Before Tax Income-9.95M-14.88M-12.36M-5.05M-4.41M-4.86M-931.66K-1.57M-69.46K
Income Tax ExpensesN/A-144.83K42.52K157.10K-13.93K-146.39K-898.43K-21.50KN/A
Net Income-9.95M-14.88M-12.40M-5.20M-4.40M-4.86M-931.66K-1.57M-69.46K
Interest Expenses10.10K7.70K46.52K158.80KN/AN/AN/AN/AN/A
Basic Shares Outstanding676.00K650.00K593.00K484.00K475.00K392.00K568.70K192.00K165.00K
Diluted Shares Outstanding676.57K650.13K593.97K484.33K475.02K392.29K568.70K192.01K165.30K
EBITDA-9.89M-14.85M-12.32MN/AN/AN/A7.34K-21.50KN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-9.94M-15.02M-12.32M-4.89M-4.41M-5.01M-1.83M-1.59M-69.46K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙